These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 10844138)

  • 1. [Nphe(1)]nociceptin-(1-13)NH(2) selectively antagonizes nociceptin effects in the rabbit isolated ileum.
    Pheng LH; Calo G; Guerrini R; Regoli D
    Eur J Pharmacol; 2000 Jun; 397(2-3):383-8. PubMed ID: 10844138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nphe(1)]nociceptin-(1-13)-NH(2) antagonizes nociceptin effects in the mouse colon.
    Rizzi A; Bigoni R; Caló G; Guerrini R; Salvadori S; Regoli D
    Eur J Pharmacol; 1999 Dec; 385(2-3):R3-5. PubMed ID: 10607891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist.
    Calo' G; Guerrini R; Bigoni R; Rizzi A; Marzola G; Okawa H; Bianchi C; Lambert DG; Salvadori S; Regoli D
    Br J Pharmacol; 2000 Mar; 129(6):1183-93. PubMed ID: 10725267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
    Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
    Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H; Calo' G; Albrecht E; Guerrini R; Bienert M
    J Pharmacol Exp Ther; 2000 Aug; 294(2):428-33. PubMed ID: 10900215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
    Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
    J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nociceptin/orphanin FQ and the pseudopeptide [Phe1Psi(CH2NH)Gly2]-nociceptin(1-13)-NH2 and their interaction with classic opioids in the modulation of thermonociception in the land snail Helix aspersa.
    Miller-Pérez C; Sánchez-Islas E; Pellicer F; Rodríguez-Manzo G; Cruz SL; León-Olea M
    Eur J Pharmacol; 2008 Feb; 581(1-2):77-85. PubMed ID: 18096155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies.
    Bigoni R; Rizzi D; Rizzi A; Camarda V; Guerrini R; Lambert DG; Hashiba E; Berger H; Salvadori S; Regoli D; Calo' G
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):442-9. PubMed ID: 12070757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
    Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nphe(1)]N/OFQ-(1-13)-NH(2) is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K(+) channel activation in rat periaqueductal gray slices.
    Chiou LC; Fan SH; Guerrini R; Caló G
    Neuropharmacology; 2002 Feb; 42(2):246-52. PubMed ID: 11804621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The putative OP(4) antagonist, [Nphe(1)]nociceptin(1-13)NH(2), prevents the effects of nociceptin in neuropathic rats.
    Corradini L; Briscini L; Ongini E; Bertorelli R
    Brain Res; 2001 Jun; 905(1-2):127-33. PubMed ID: 11423087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ORL-1 receptor mediates the action of nociceptin on ascending myenteric reflex pathways in rats.
    Yüce B; Sibaev A; Haaken A; Saur D; Allescher HD; Göke B; Timmermans JP; Storr M
    Gastroenterology; 2007 Aug; 133(2):574-86. PubMed ID: 17681177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A.
    Guerrini R; Calo' G; Rizzi A; Bigoni R; Rizzi D; Regoli D; Salvadori S
    Peptides; 2000 Jul; 21(7):923-33. PubMed ID: 10998526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin.
    Sbrenna S; Marti M; Morari M; Calo' G; Guerrini R; Beani L; Bianchi C
    Br J Pharmacol; 2000 May; 130(2):425-33. PubMed ID: 10807682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre- and postsynaptic inhibition by nociceptin in guinea pig small intestinal myenteric plexus in vitro.
    Liu S; Hu HZ; Ren J; Gao C; Gao N; Lin Z; Xia Y; Wood JD
    Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G237-46. PubMed ID: 11408277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata. A microdialysis study in the awake freely moving rat.
    Marti M; Guerrini R; Beani L; Bianchi C; Morari M
    Neuroscience; 2002; 112(1):153-60. PubMed ID: 12044480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-RYYRIK-NH(2) is a highly efficacious OP(4) receptor agonist in the cardiovascular system of anesthetized rats.
    Malinowska B; Kozłowska H; Berger H; Schlicker E
    Peptides; 2000 Dec; 21(12):1875-80. PubMed ID: 11150649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.
    Ho M; Corbett AD; McKnight AT
    Br J Pharmacol; 2000 Sep; 131(2):349-55. PubMed ID: 10991930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of Ac-RYYRWK-NH(2), Ac-RYYRIK-NH(2) and [Phe1Psi(CH(2)-NH)Gly2] nociceptin(1-13)NH(2) at rat native and recombinant ORL(1) receptors.
    Mason SL; Ho M; Nicholson J; McKnight AT
    Neuropeptides; 2001; 35(5-6):244-56. PubMed ID: 12030809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
    Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
    J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.